Trials / Conditions / Refractory Mycosis Fungoides and Sezary Syndrome
Refractory Mycosis Fungoides and Sezary Syndrome
3 registered clinical trials studyying Refractory Mycosis Fungoides and Sezary Syndrome.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogam NCT04541017 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatme NCT03063632 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndro NCT02243579 | National Cancer Institute (NCI) | Phase 2 |